07:00 , May 23, 2005 |  BioCentury  |  Finance

U.S. investment in Europe

U.S. investment in Europe Company Name Country Raised Investors Arpida Switzerland $67.4 Swissfirst; Temasek Capital; Carnegie Asset Management; CDIB BioScience Ventures; CITA; MVI Medical Venture Investments; Schroder Ventures Life Sciences; Alta Berkeley Associates; Aventic; BioMedinvest;...
08:00 , Jan 12, 2004 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Revotar Biopharmaceuticals AG Berlin, Germany Technology: Rational drug design Disease focus: Dermatological and respiratory diseases and sepsis Clinical status: Phase IIa Founded: 2000 by Encysive Pharmaceuticals Inc. Corporate partners: None University collaborators: University Hospital RWTH...
08:00 , Dec 11, 2003 |  BC Extra  |  Company News

Revotar's Rosskamp leaves

Inflammation company Revotar (Berlin, Germany) said CEO Guenter Rosskamp has departed. He has been replaced by executive board members Stephen Tarlach and Marc Voigt, previously non-executive board members and investment managers at BMP AG and...
07:00 , May 21, 2001 |  BC Week In Review  |  Company News

Jerini board of directors update

Jerini AG, Berlin, Germany   Business: Chemistry, Proteomics   Appointed: Karl-Gerhard Seifert, chairman of Deutsche Morgan Grenfell Equity, as chairman; Stephen Goetz, EVP of international operations of Communications Equity Associates (CEA) USA and managing director...